Superworth

QuidelOrtho revenue QDEL

Sales by quarter and over the last twelve months, from 2021.

Last 12 months, to Jun 28, 2026
$2.7B
Latest quarter, Q2 FY26
$630.9M
+3% on a year earlier
Fiscal year 2025
$2.7B
−2% on the year before

QuidelOrtho's revenue was $2.7B over the twelve months to Jun 28, 2026, down 2% on a year earlier.

In its latest quarter, Q2 FY26, it was $630.9M, up 3% on the same quarter a year before.

Revenue over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearRevenueChange
FY2025$2.7B−2%
FY2024$2.8B−7%
FY2023$3B−8%
FY2022$3.3B+92%
FY2021$1.7Bn/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedRevenueOn a year earlierLast 12 months
Q2 FY26$630.9M+3%$2.7B
Q1 FY26$619.8M−11%$2.7B
Q4 FY25$723.6M+2%$2.7B
Q3 FY25$699.9M−4%$2.7B
Q2 FY25$613.9M−4%$2.7B
Q1 FY25$692.8M−3%$2.8B
Q4 FY24$707.8M−5%$2.8B
Q3 FY24$727.1M−2%$2.8B
Q2 FY24$637M−4%$2.8B
Q1 FY24$711M−16%$2.9B
Q4 FY23$742.6M−14%$3B
Q3 FY23$744M−5%$3.1B

Against its peers

Companies in Medical - Diagnostics & Research nearest QuidelOrtho's size, closest first, today.

CompanyRevenue, 12 monthsGrowth
QDELQuidelOrtho$2.7B−2% a year
NRCNRC Health$140M−0% a year
CDNACareDx$458.1M+34% a year
VCYTVeracyte$561.9M+17% a year
BLLNBillionToOne$397.4M+90% a year
LNTHLantheus$1.6B+2% a year
CAICaris Life Sciences$989.6M+85% a year
Peer median$510M

Where QuidelOrtho ranks

What the revenue tells you

Total sales in the period. On the company page, quarterly bars or the trailing twelve months (TTM), which smooths seasonality.

Growing revenue with shrinking margins is a warning, not a win.

More on QuidelOrtho

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.